6-3153878-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000333628.4(TUBB2A):c.1323C>T(p.Gly441=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,613,926 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0082 ( 9 hom., cov: 30)
Exomes 𝑓: 0.00085 ( 15 hom. )
Consequence
TUBB2A
ENST00000333628.4 synonymous
ENST00000333628.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.34
Genes affected
TUBB2A (HGNC:12412): (tubulin beta 2A class IIa) Microtubules, key participants in processes such as mitosis and intracellular transport, are composed of heterodimers of alpha- and beta-tubulins. The protein encoded by this gene is a beta-tubulin. Defects in this gene are associated with complex cortical dysplasia with other brain malformations-5. Two transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 6-3153878-G-A is Benign according to our data. Variant chr6-3153878-G-A is described in ClinVar as [Benign]. Clinvar id is 382896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-3153878-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.34 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00819 (1245/152096) while in subpopulation AFR AF= 0.0283 (1175/41482). AF 95% confidence interval is 0.027. There are 9 homozygotes in gnomad4. There are 564 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1245 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB2A | NM_001069.3 | c.1323C>T | p.Gly441= | synonymous_variant | 4/4 | ENST00000333628.4 | NP_001060.1 | |
TUBB2A | NM_001310315.2 | c.1068C>T | p.Gly356= | synonymous_variant | 4/4 | NP_001297244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB2A | ENST00000333628.4 | c.1323C>T | p.Gly441= | synonymous_variant | 4/4 | 1 | NM_001069.3 | ENSP00000369703 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00817 AC: 1241AN: 151978Hom.: 9 Cov.: 30
GnomAD3 genomes
AF:
AC:
1241
AN:
151978
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00224 AC: 563AN: 251454Hom.: 3 AF XY: 0.00152 AC XY: 207AN XY: 135900
GnomAD3 exomes
AF:
AC:
563
AN:
251454
Hom.:
AF XY:
AC XY:
207
AN XY:
135900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000850 AC: 1243AN: 1461830Hom.: 15 Cov.: 31 AF XY: 0.000733 AC XY: 533AN XY: 727202
GnomAD4 exome
AF:
AC:
1243
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
533
AN XY:
727202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00819 AC: 1245AN: 152096Hom.: 9 Cov.: 30 AF XY: 0.00759 AC XY: 564AN XY: 74354
GnomAD4 genome
AF:
AC:
1245
AN:
152096
Hom.:
Cov.:
30
AF XY:
AC XY:
564
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at